Inotiv seeks incentive to double Westminster pharma operation

WESTMINSTER — Inotiv Boulder LLC, the local affiliate of Inotiv Inc. (Nasdaq: NOTV), is planning to double its Westminster pharmaceutical research and laboratory operations, which the Indiana company acquired last year in its acquisition of a Westminster-based in vivo pharmacology and drug-discovery company Plato BioPharma Inc.

Westminster city officials could sweeten the pot for Inotiv, which cited previously revealed plans Plato had for expanding the 7581 W. 103rd Ave. facility to about 20,000 square feet, with the approval of tax- and fee-incentive package not to exceed $68,755 that was introduced Monday and approval on first reading without discussion.

The city expects Inotiv…